SCHEMBL4284310

SCHEMBL4284310

CCn1c(-c2c[nH]nc2Cc2cccc(F)c2)nc2c1c(=O)[nH]c(=O)n2C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.54
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
IDO1 P14902 2/20 0.44
BRDT Q58F21 1/20 0.43
TP53 P04637 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
POLB P06746 3/20 0.42
MAPT P10636 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 3/20 0.42
HTT P42858 2/20 0.42
KDM4E B2RXH2 1/20 0.42
KDR P35968 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CXCL8 P10145 1/20 0.41
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4291739 0.94 KDM1A (0.60) KDM1AMEN1KMT2AIDO1BRDT
SCHEMBL4285483 0.92 MEN1 (0.54) KDM1AMEN1KMT2AIDO1TP53
SCHEMBL4016883 0.85 TPH1 (0.44) KDM1AMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL4018480 0.79 TPH1 (0.50) KDM1AMEN1KMT2AIDO1SMN1; SMN2
SCHEMBL5509419 0.79 ADORA3 (0.44) KDM1AMEN1KMT2AIDO1TP53
SCHEMBL4016181 0.77 MEN1 (0.42) KDM1AMEN1KMT2AMAPTALDH1A1
SCHEMBL5061625 0.75 TPH1 (0.48) MEN1KMT2ASMN1; SMN2POLBALDH1A1
SCHEMBL4019166 0.74 NOD1 (0.37) KDM1AMEN1KMT2ABRDTNOD1
SCHEMBL4014400 0.73 ADORA2A (0.41) MEN1KMT2A
SCHEMBL4014662 0.72 ADORA2B (0.50) ALDH1A1KDM4EHPGDHSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009157938-A1 A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING CANCER CV THERAPEUTICS, INC. (US) 2009-12-30 WO disclosed